Savara Enters Into Non-Dilutive Debt Financing for up to $200M With Hercules Capital
Savara Inc. (Nasdaq: SVRA) (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, ...
From inflammation to fibrosis: Research explores cellular changes as COVID-19 lung damage ...
Researchers have uncovered changes in the cellular response throughout lung damage caused by SARS-CoV-2—the virus behind COVID-19. The team revealed distinct phases where waves of immune responses ...
WebMD7 年
Vitamins by Condition
Considering taking supplements to treat alveolar osteitis? Below is a list of common natural remedies used to treat or reduce the symptoms of alveolar osteitis. Follow the links to read common ...
AZoLifeSciences on MSN14 天
Cellular changes as lung damage worsens in COVID-19 revealed
Changes in the cellular response during lung damage caused by SARS-CoV-2 – the virus behind COVID-19 – have been uncovered. Researchers reveal distinct phases where waves of immune responses give way ...
Pharmabiz1 个月
Chugai obtains Japanese regulatory approval for Tecentriq for additional indication of ...
Tecentriq is the first immune checkpoint inhibitor in Japan for the treatment of this disease. “We are very pleased that we can offer Tecentriq as a new treatment for unresectable alveolar soft part ...
PipelineReview.com8 天
SMSbiotech Receives Green Light for Phase I Clinical Trial in Australia, Targeting COPD
SAN MARCOS, CA, USA I March 18, 2025 I SMSbiotech has announced a significant milestone in its pursuit of its regenerative medicine technology, securing ...